Free Trial
OTCMKTS:CYDY

CytoDyn (CYDY) Stock Price, News & Analysis

CytoDyn logo
$0.31 +0.01 (+2.14%)
As of 01:57 PM Eastern

About CytoDyn Stock (OTCMKTS:CYDY)

Key Stats

Today's Range
$0.30
$0.31
50-Day Range
$0.26
$0.43
52-Week Range
$0.10
$0.49
Volume
332,603 shs
Average Volume
2.97 million shs
Market Capitalization
$388.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CYDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CytoDyn and its competitors with MarketBeat's FREE daily newsletter.

CYDY Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
CytoDyn Releases ESMO Breast Cancer Meeting Poster
See More Headlines

CYDY Stock Analysis - Frequently Asked Questions

CytoDyn's stock was trading at $0.1097 at the start of the year. Since then, CYDY stock has increased by 183.0% and is now trading at $0.3105.

CytoDyn Inc. (OTCMKTS:CYDY) posted its quarterly earnings data on Tuesday, April, 13th. The biotechnology company reported ($0.06) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by $0.01.

Shares of CYDY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that CytoDyn investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and iShares Micro-Cap ETF (IWC).

Company Calendar

Last Earnings
4/13/2021
Today
7/17/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
5/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:CYDY
Previous Symbol
NASDAQ:CYDY
CIK
1175680
Fax
N/A
Employees
20
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-33.26%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.30
Quick Ratio
0.30

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.11) per share
Price / Book
-2.76

Miscellaneous

Outstanding Shares
1,251,530,000
Free Float
1,244,776,000
Market Cap
$380.47 million
Optionable
Not Optionable
Beta
1.17

Social Links

Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (OTCMKTS:CYDY) was last updated on 7/17/2025 by MarketBeat.com Staff
From Our Partners